Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8659750 | Heart, Lung and Circulation | 2018 | 8 Pages |
Abstract
Over 80% of patients who survive Fontan surgery will be alive at 20 years. Developing late sequelae including protein losing enteropathy, ventricular dysfunction or requiring a pacemaker predict a higher risk of late death.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
C.L. MBBS, Y. MD, PhD,